A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung cancer
Phase 2
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000029435
- Lead Sponsor
- Department of respiratory medicine, Kurashiki Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of severe hypersensitivity to taxane group 2. History of severe hypersensitivity to Carboplatin 3. History of severe hypersensitivity to albumin preparation 4. Interstitial lung disease or pulmonary fibrosis 5. Severe infectious disease or severe uncontrolled complication 6. Active malignancy of other organ 7. HBs antigen positive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method